Pharma Research
Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into a joint research agreement with JCR Pharma...
December 14, 2023 | News
This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...
December 13, 2023 | News
In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...
December 13, 2023 | News
Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...
December 05, 2023 | News
XtalPi, a leading global technology company, is renowned for its expertise in integrating physics-based computation, artificial intelligence (AI), and robo...
November 28, 2023 | News
The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...
November 23, 2023 | News
In the collaboration with Lipotype GmbH, Germany (the world leader in lipidomics profiling service), T-BAL has developed advanced multi-omics (ma...
November 20, 2023 | News
The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...
November 17, 2023 | News
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...
November 17, 2023 | News
CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...
November 14, 2023 | News
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate p...
November 10, 2023 | News
"We are looking forward to expanding our relationship with Bristol Myers Squibb and furthering our shared commitment to advancing cancer research and treat...
November 09, 2023 | News
Agreement to focus on joint cancer target identification and discovery of new therapeutic approaches Extended collaboration strengthens Bayer's precisio...
November 03, 2023 | News
CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in ma...
November 02, 2023 | News
Most Read
Bio Jobs
News
Editor Picks